280 related articles for article (PubMed ID: 31536685)
41. Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial.
Noronha V; Joshi A; Patil VM; Agarwal J; Ghosh-Laskar S; Budrukkar A; Murthy V; Gupta T; D'Cruz AK; Banavali S; Pai PS; Chaturvedi P; Chaukar D; Pande N; Chandrasekharan A; Talreja V; Vallathol DH; Mathrudev V; Manjrekar A; Maske K; Bhelekar AS; Nawale K; Kannan S; Gota V; Bhattacharjee A; Kane S; Juvekar SL; Prabhash K
J Clin Oncol; 2018 Apr; 36(11):1064-1072. PubMed ID: 29220295
[TBL] [Abstract][Full Text] [Related]
42. Gastrostomy versus nasogastric tube feeding for chemoradiation patients with head and neck cancer: the TUBE pilot RCT.
Paleri V; Patterson J; Rousseau N; Moloney E; Craig D; Tzelis D; Wilkinson N; Franks J; Hynes AM; Heaven B; Hamilton D; Guerrero-Urbano T; Donnelly R; Barclay S; Rapley T; Stocken D
Health Technol Assess; 2018 Apr; 22(16):1-144. PubMed ID: 29650060
[TBL] [Abstract][Full Text] [Related]
43. Effect of Eicosapentaenoic Acid on Body Composition and Inflammation Markers in Patients with Head and Neck Squamous Cell Cancer from a Public Hospital in Mexico.
Solís-Martínez O; Plasa-Carvalho V; Phillips-Sixtos G; Trujillo-Cabrera Y; Hernández-Cuellar A; Queipo-García GE; Meaney-Mendiolea E; Ceballos-Reyes GM; Fuchs-Tarlovsky V
Nutr Cancer; 2018; 70(4):663-670. PubMed ID: 29697274
[TBL] [Abstract][Full Text] [Related]
44. A phase I study of cabazitaxel in combination with platinum and 5-fluorouracil (PF) in locally advanced squamous cell carcinoma of head and neck (LA-SCCHN).
Camille N; Rozehnal J; Roy E; Uczkowski D; Olson A; Genden E; Teng M; Bakst R; Gupta V; Posner M; Misiukiewicz K
Oral Oncol; 2017 Aug; 71():99-104. PubMed ID: 28688700
[TBL] [Abstract][Full Text] [Related]
45. Combined Nimotuzumab with Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma.
Thai Hoa NT; Quang Huy H
Cureus; 2020 May; 12(5):e8105. PubMed ID: 32426197
[TBL] [Abstract][Full Text] [Related]
46. Prognostic impact of extranodal extension in resected head and neck squamous cell carcinomas in the era of postoperative chemoradiation: A retrospective monocentric study.
Gau M; Fonseca A; Ozsahin M; Fayette J; Poupart M; Roux PE; Schütz F; Zrounba P; Grégoire V
Oral Oncol; 2021 Dec; 123():105605. PubMed ID: 34800789
[TBL] [Abstract][Full Text] [Related]
47. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
[TBL] [Abstract][Full Text] [Related]
48. A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck.
Enokida T; Ogawa T; Homma A; Okami K; Minami S; Nakanome A; Shimizu Y; Maki D; Ueda Y; Fujisawa T; Motegi A; Ohkoshi A; Taguchi J; Ebisumoto K; Nomura S; Okano S; Tahara M
Cancer Med; 2020 Mar; 9(5):1671-1682. PubMed ID: 31943834
[TBL] [Abstract][Full Text] [Related]
49. Definitive radiation with concurrent cetuximab vs. radiation with or without concurrent cytotoxic chemotherapy in older patients with squamous cell carcinoma of the head and neck: Analysis of the SEER-medicare linked database.
Zandberg DP; Cullen K; Bentzen SM; Goloubeva OG
Oral Oncol; 2018 Nov; 86():132-140. PubMed ID: 30409293
[TBL] [Abstract][Full Text] [Related]
50. Quality of life in patients with locally advanced head and neck cancer treated with concurrent chemoradiation with cisplatin and nimotuzumab versus cisplatin alone - Additional data from a phase 3 trial.
Menon N; Patil V; Noronha V; Joshi A; Bhattacharjee A; Satam BJ; Mathrudev V; Ghosh Laskar S; Prabhash K
Oral Oncol; 2021 Nov; 122():105517. PubMed ID: 34560383
[TBL] [Abstract][Full Text] [Related]
51. Association of handgrip strength and endurance with body composition in head and neck cancer patients.
Kowshik V; Velkumary S; Sethi P; Feula JM; Subhashri S; Abirami M
J Family Med Prim Care; 2021 Feb; 10(2):910-916. PubMed ID: 34041097
[TBL] [Abstract][Full Text] [Related]
52. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
[TBL] [Abstract][Full Text] [Related]
53. Nutritional Counseling for Head and Neck Cancer Patients Undergoing (Chemo) Radiotherapy-A Prospective Randomized Trial.
Orell H; Schwab U; Saarilahti K; Österlund P; Ravasco P; Mäkitie A
Front Nutr; 2019; 6():22. PubMed ID: 30937304
[No Abstract] [Full Text] [Related]
54. Patterns, Predictors, and Prognostic Value of Skeletal Muscle Mass Loss in Patients with Locally Advanced Head and Neck Cancer Undergoing Cisplatin-Based Chemoradiotherapy.
Chargi N; Wegner I; Markazi N; Smid E; de Jong P; Devriese L; de Bree R
J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33919607
[TBL] [Abstract][Full Text] [Related]
55. Correlation Between Early Time-to-Event Outcomes and Overall Survival in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Receiving Definitive Chemoradiation Therapy: Systematic Review and Meta-Analysis.
Black CM; Keeping S; Mojebi A; Ramakrishnan K; Chirovsky D; Upadhyay N; Maciel D; Ayers D
Front Oncol; 2022; 12():868490. PubMed ID: 35574411
[TBL] [Abstract][Full Text] [Related]
56. Sarcopenia in male patients with head and neck cancer receiving chemoradiotherapy: a longitudinal pilot study.
Chauhan NS; Samuel SR; Meenar N; Saxena PP; Keogh JWL
PeerJ; 2020; 8():e8617. PubMed ID: 32149024
[TBL] [Abstract][Full Text] [Related]
57. A randomized trial of adjunct testosterone for cancer-related muscle loss in men and women.
Wright TJ; Dillon EL; Durham WJ; Chamberlain A; Randolph KM; Danesi C; Horstman AM; Gilkison CR; Willis M; Richardson G; Hatch SS; Jupiter DC; McCammon S; Urban RJ; Sheffield-Moore M
J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):482-496. PubMed ID: 29654645
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of Curcumin on Treating Cancer Anorexia-Cachexia Syndrome in Locally or Advanced Head and Neck Cancer: A Double-Blind, Placebo-Controlled Randomised Phase IIa Trial (CurChexia).
Thambamroong T; Seetalarom K; Saichaemchan S; Pumsutas Y; Prasongsook N
J Nutr Metab; 2022; 2022():5425619. PubMed ID: 35694030
[TBL] [Abstract][Full Text] [Related]
59. Continued Weight Loss and Sarcopenia Predict Poor Outcomes in Locally Advanced Pancreatic Cancer Treated with Chemoradiation.
Naumann P; Eberlein J; Farnia B; Hackert T; Debus J; Combs SE
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31126040
[No Abstract] [Full Text] [Related]
60. A Single-institution Comparison of Cetuximab, Carboplatin, and Paclitaxel Induction Chemotherapy Followed by Chemoradiation (CRT) Versus CRT for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN).
Grover S; Mitra N; Wan F; Lukens JN; Sharma S; Bauman J; Masroor F; Cohen RB; Desai A; Algazy K; Alonso-Basanta M; Ahn P; Kevin Teo BK; Chalian AA; Weinstein GS; O'Malley BW; Lin A
Am J Clin Oncol; 2016 Oct; 39(5):522-7. PubMed ID: 27441910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
